Literature DB >> 33759226

In it together? The case for endocannabinoid-noradrenergic interactions in fear extinction.

William G Warren1, Eleni P Papagianni1, Carl W Stevenson1, Christine Stubbendorff1,2.   

Abstract

Anxiety and trauma-related disorders, such as post-traumatic stress disorder (PTSD), are debilitating mental illnesses with great personal and socioeconomic costs. Examining memory formation and relevant behavioural responding associated with aversive stimuli may improve our understanding of the neurobiology underlying fear memory processing and PTSD treatment. The neurocircuitry underpinning learned fear and its inhibition through extinction is complex, involving synergistic interactions between different neurotransmitter systems in inter-connected brain areas. Endocannabinoid and noradrenergic transmission have both been implicated separately in fear memory processing and PTSD, but potential interactions between these systems in relation to fear extinction have received little attention to date. Their receptors are expressed together in brain areas crucial for fear extinction, which is enhanced by both cannabinoid and noradrenergic receptor activation in these areas. Moreover, cannabinoid signalling modulates the activity of locus coeruleus noradrenaline (NA) neurons and the release of NA in the medial prefrontal cortex, a brain area that is crucial for fear extinction. Interestingly, endocannabinoid-noradrenergic system interactions have been shown to regulate the encoding and retrieval of fear memory. Thus, noradrenergic regulation of fear extinction may also be driven indirectly in part via cannabinoid receptor signalling. In this perspective paper, we collate the available relevant literature and propose a synergistic role for the endocannabinoid and noradrenergic systems in regulating fear extinction, the study of which may further our understanding of the neurobiological substrates of PTSD and its treatment.
© 2021 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  amygdala; cannabinoid; hippocampus; noradrenaline; prefrontal

Mesh:

Substances:

Year:  2021        PMID: 33759226     DOI: 10.1111/ejn.15200

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  3 in total

1.  Cannabinoid Receptor 1 rs1049353 Variant, Childhood Abuse, and the Heterogeneity of PTSD Symptoms: Results From the National Health and Resilience in Veterans Study.

Authors:  Nachshon Korem; Or Duek; Ke Xu; Ilan Harpaz-Rotem; Robert H Pietrzak
Journal:  Chronic Stress (Thousand Oaks)       Date:  2021-04-29

2.  URB597 induces subtle changes to aggression in adult Lister Hooded rats.

Authors:  William G Warren; Ed Hale; Eleni P Papagianni; Helen J Cassaday; Carl W Stevenson; Christine Stubbendorff
Journal:  Front Psychiatry       Date:  2022-08-12       Impact factor: 5.435

3.  Cannabidiol Prevents Spontaneous Fear Recovery after Extinction and Ameliorates Stress-Induced Extinction Resistance.

Authors:  Eleni P Papagianni; William G Warren; Helen J Cassaday; Carl W Stevenson
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.